Form 4 for MAIA MAIA Biotechnology, Inc.
Accepted 2026-06-02 09:00:31 ET · period of report 2026-06-01 · accession 0001878313-26-000060 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 09:00 | 2026-06-01 | MAIA | Gryaznov Sergei | CSO | P - Purchase | $1.34 | +2,000 | 46.5K | +4% | +$2,690 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | P | A | 2,000 | $1.34 | 46,511 | D | — | — |